Medicare Enrolled

Dr. Sarah Ali, MD

Hematology & Oncology · Mission Hills, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
15031 RINALDI ST STE 150, Mission Hills, CA 91345
8186604700
In practice since 2008 (18 years)
NPI: 1558547588 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ali? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ali

Dr. Sarah Ali is a hematology & oncology specialist in Mission Hills, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ali performed 2,892 Medicare services across 191 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ali received a total of $9,500 from 51 pharmaceutical and/or device companies across 542 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 38% volume in CA $9,500 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,892
Medicare services
Top 38% in CA for hematology & oncology
191
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~161 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Anti-nausea injection (aprepitant) 2,080 $1 $6
Anti-nausea injection (ondansetron/Zofran) 352 $0 $0
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
250 $0 $0
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
63 $14 $93
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
38 $123 $606
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
27 $113 $481
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
20 $158 $672
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
19 $13 $81
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
16 $60 $295
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
15 $27 $147
New patient office visit, complex (60-74 min) 12 $193 $821
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.4% high complexity
95.6% medium
2.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,500
Total received (2018-2024)
Avg $1,357/year across 7 years
Top 33% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
542
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,233 (86.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,267 (13.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$87
2023
$224
2022
$371
2021
$42
2020
$1,994
2019
$3,634
2018
$3,149

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ImmunoGen, Inc.
$87
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$1,162
AstraZeneca Pharmaceuticals LP
$1,160
Rigel Pharmaceuticals, Inc.
$1,000
Genentech USA, Inc.
$627
Merck Sharp & Dohme Corporation
$613
Novartis Pharmaceuticals Corporation
$599
Janssen Biotech, Inc.
$567
PFIZER INC.
$463
Pharmacyclics LLC, An AbbVie Company
$375
Amgen Inc.
$213
Clovis Oncology, Inc.
$189
Astellas Pharma US Inc
$182
Celgene Corporation
$161
Janssen Pharmaceuticals, Inc
$160
Exelixis Inc.
$150
EISAI INC.
$136
GENZYME CORPORATION
$132
Bayer HealthCare Pharmaceuticals Inc.
$117
Intuitive Surgical, Inc.
$110
Puma Biotechnology, Inc.
$93
Alexion Pharmaceuticals, Inc.
$88
ImmunoGen, Inc.
$87
Janssen Scientific Affairs, LLC
$80
Lilly USA, LLC
$77
Gilead Sciences, Inc.
$74
Eisai Inc.
$69
Seagen Inc.
$66
Foundation Medicine, Inc.
$63
Sandoz Inc.
$56
TerSera Therapeutics LLC
$53
Incyte Corporation
$53
Daiichi Sankyo Inc.
$52
AbbVie, Inc.
$45
Ipsen Biopharmaceuticals, Inc
$44
EMD Serono, Inc.
$44
TESARO, Inc.
$43
Verastem, Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Teva Pharmaceuticals USA, Inc.
$26
GlaxoSmithKline, LLC.
$24
Myovant Sciences Inc.
$24
INSYS Therapeutics Inc
$24
Partner Therapeutics, Inc.
$19
Sobi, Inc
$18
Array BioPharma Inc.
$17
Merck Sharp & Dohme LLC
$16
Taiho Oncology, Inc.
$15
Aurobindo Pharma USA, Inc.
$15
Dova Pharmaceuticals
$13
Helsinn Therapeutics (U.S.), Inc.
$13
Kyowa Kirin, Inc.
$11
Top 3 companies account for 35.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · Abraxane · Alecensa · Aranesp · Avastin · BENDEKA · BOSULIF · Balversa · Bavencio · Braftovi · CALQUENCE · CEREZYME · CHANTIX · CYRAMZA · Cabometyx · Copiktra · Creon · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ERBITUX · Erleada · FOUNDATIONONE · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MVASI · NERLYNX · NOXAFIL · Nerlynx · Neulasta · Nplate · OPDIVO · ORGOVYX · Onivyde · PADCEV · PIQRAY · POTELIGEO · PREVNAR - 13 · PREVNAR 13 · PROMACTA · Perjeta · Pomalyst · RETEVMO · RYDAPT · Revlimid · Rubraca · SANDOSTATIN LAR · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · ULTOMIRIS · VENCLEXTA · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XTANDI · Xofigo · Xtandi · ZARXIO · ZEJULA · ZERBAXA · ZOLADEX · ZYTIGA · Zevalin · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Mission Hills?
Compare hematology & oncology specialists in the Mission Hills area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
286
Per 100K population
2.9
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - PANORAMA CITY
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ali is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ali experienced with anti-nausea injection (aprepitant)?
Based on Medicare claims data, Dr. Ali performed 2,080 anti-nausea injection (aprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ali receive payments from pharmaceutical companies?
Yes. Dr. Ali received a total of $9,500 from 51 companies across 542 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ali's costs compare to other hematology & oncology specialists in Mission Hills?
Dr. Ali's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →